Literature DB >> 19638080

A randomized, controlled trial of banding ligation plus drug therapy versus drug therapy alone in the prevention of esophageal variceal rebleeding.

Gin-Ho Lo1, Wen-Chi Chen, Hoi-Hung Chan, Wei-Lun Tsai, Ping-I Hsu, Chiun-Ku Lin, Tai-An Chen, Kwok-Hung Lai.   

Abstract

BACKGROUND & AIMS: Both medications with beta-blockers and isosorbide-5-mononitrate and endoscopic variceal ligation have been proven plausible in the prevention of variceal rebleeding. However, the relative efficacy and safety of the combined treatment for preventing rebleeding remains unresolved.
METHODS: Patients with history of esophageal variceal bleeding were enrolled. Emergency ligation was performed in patients with acute variceal bleeding. After hemodynamic stability, eligible patients were randomized to either the Medication group, using nadolol plus isorsorbide-5-mononitrate, or the Combined group, receiving banding ligation in addition to medications. Patients in the two groups with rebleeding from esophageal varices were treated with band ligation. The end points were rebleeding from varices or death.
RESULTS: After a median follow up of 23 months, recurrent upper gastrointestinal bleeding developed in 51% in the Medication group and 38% in the Combined group (P = 0.21). Recurrent bleeding from esophageal varices occurred in 26 patients (43%) in the Medication group and in 16 patients (26%) in the Combined group (P = 0.07). Recurrent bleeding from gastroesophageal varices occurred in 48% of Medication group and 28% of Combined group (P = 0.05). The frequency of adverse effects and mortality rates were similar between both groups (P = 0.28).
CONCLUSIONS: Combined ligation with medications was marginally more effective than medication alone in the prevention of gastroesophageal variceal rebleeding with similar adverse effects and mortality.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19638080     DOI: 10.1111/j.1440-1746.2009.05792.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  12 in total

1.  Stratifying risk in the prevention of recurrent variceal hemorrhage: Results of an individual patient meta-analysis.

Authors:  Agustín Albillos; Javier Zamora; Javier Martínez; David Arroyo; Irfan Ahmad; Joaquin De-la-Peña; Juan-Carlos Garcia-Pagán; Gin-Ho Lo; Shiv Sarin; Barjesh Sharma; Juan G Abraldes; Jaime Bosch; Guadalupe Garcia-Tsao
Journal:  Hepatology       Date:  2017-08-26       Impact factor: 17.425

Review 2.  Clinical pharmacology of portal hypertension.

Authors:  Cecilia Miñano; Guadalupe Garcia-Tsao
Journal:  Gastroenterol Clin North Am       Date:  2010-09       Impact factor: 3.806

Review 3.  Role of endoscopy in management of gastrointestinal complications of portal hypertension.

Authors:  Carmelo Luigiano; Giuseppe Iabichino; Antonino Judica; Clara Virgilio; Valentina Peta; Ludovico Abenavoli
Journal:  World J Gastrointest Endosc       Date:  2015-01-16

Review 4.  Endoscopic treatments for portal hypertension.

Authors:  Gin-Ho Lo
Journal:  Hepatol Int       Date:  2017-11-07       Impact factor: 6.047

Review 5.  Organic nitrate metabolism and action: toward a unifying hypothesis and the future-a dedication to Professor Leslie Z. Benet.

Authors:  Nathaniel A Page; Ho-Leung Fung
Journal:  J Pharm Sci       Date:  2013-05-13       Impact factor: 3.534

Review 6.  Portal hypertension and gastrointestinal bleeding: diagnosis, prevention and management.

Authors:  Erwin Biecker
Journal:  World J Gastroenterol       Date:  2013-08-21       Impact factor: 5.742

7.  Primary prevention of variceal bleeding in people with oesophageal varices due to liver cirrhosis: a network meta-analysis.

Authors:  Davide Roccarina; Lawrence Mj Best; Suzanne C Freeman; Danielle Roberts; Nicola J Cooper; Alex J Sutton; Amine Benmassaoud; Maria Corina Plaz Torres; Laura Iogna Prat; Mario Csenar; Sivapatham Arunan; Tanjia Begum; Elisabeth Jane Milne; Maxine Tapp; Chavdar S Pavlov; Brian R Davidson; Emmanuel Tsochatzis; Norman R Williams; Kurinchi Selvan Gurusamy
Journal:  Cochrane Database Syst Rev       Date:  2021-04-06

8.  Secondary prevention of variceal bleeding in adults with previous oesophageal variceal bleeding due to decompensated liver cirrhosis: a network meta-analysis.

Authors:  Maria Corina Plaz Torres; Lawrence Mj Best; Suzanne C Freeman; Danielle Roberts; Nicola J Cooper; Alex J Sutton; Davide Roccarina; Amine Benmassaoud; Laura Iogna Prat; Norman R Williams; Mario Csenar; Dominic Fritche; Tanjia Begum; Sivapatham Arunan; Maxine Tapp; Elisabeth Jane Milne; Chavdar S Pavlov; Brian R Davidson; Emmanuel Tsochatzis; Kurinchi Selvan Gurusamy
Journal:  Cochrane Database Syst Rev       Date:  2021-03-30

9.  Combination therapy versus pharmacotherapy, endoscopic variceal ligation, or the transjugular intrahepatic portosystemic shunt alone in the secondary prevention of esophageal variceal bleeding: a meta-analysis of randomized controlled trials.

Authors:  Lu-Lu Lin; Shi-Ming Du; Yan Fu; Hui-Yun Gu; Lei Wang; Zhi-Yuan Jian; Xian-Feng Shen; Jie Luo; Chao Zhang
Journal:  Oncotarget       Date:  2017-05-24

Review 10.  Gastrointestinal Bleeding in Cirrhotic Patients with Portal Hypertension.

Authors:  Erwin Biecker
Journal:  ISRN Hepatol       Date:  2013-07-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.